constant and about 5:1 in normal subject and in patients with all types of hyperlipoproteinemia, except the rare Type 3.
The other is that when chylomicrons are not detectable, most of the triglyceride in plasma is contained in the VLDL.
Thus, in the vast majority of plasma samples in which chylomicrons are not present, the cholesterol in plasma attributable to VLDL can be approximated by dividing the plasma triglyceride concentration by fine.
The justification of this method for estimation of CLDL is the subject of this paper.